Spexin (SPX), a neuropeptide discovered by the bioinformatics approach, has been recently identified as a satiety factor in a fish model. However, the functional link between feeding and SPX expression as well as the signal transduction for SPX regulation are totally unknown. In this study, we used goldfish as a model to examine the functional role of insulin as a postprandial signal for SPX regulation in bony fish. In goldfish, feeding could elevate plasma levels of glucose, insulin, and SPX with concurrent rises in insulin and SPX messenger RNA (mRNA) expression in the liver. Similar elevation in SPX mRNA level was also observed in the liver and brain areas involved in appetite control in goldfish after intraperitoneal injection of glucose and insulin, respectively. In parallel experiments with goldfish hepatocytes and brain cell culture, insulin signal induced by glucose was shown to exert a dual role in SPX regulation, namely (1) acting as an autocrine/paracrine signal to trigger SPX mRNA expression in the liver and (2) serving as an endocrine signal to induce SPX gene expression in the brain. Apparently, the peripheral (in the liver) and central actions of insulin (in the brain) on SPX gene expression were mediated by insulin receptor (to a lesser extent by insulin-like growth factor I receptor) coupled to mitogen-activated protein kinase kinase 3/6/p38 mitogenactivated protein kinase and phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin but not mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 cascades. Our findings indicate that an insulin component inducible by glucose is present in the liver of the fish model and may serve as the postprandial signal linking food intake with SPX expression both in the central as well as at the hepatic level. (Endocrinology 158: 560-577, 2017) S pexin (SPX), the protein product of the C12orf39 gene in humans, is a novel peptide first identified by bioinformatics prior to its purification/functional studies (1, 2). It is a 14-amino acid peptide with C-terminal a-amidation, and its protein sequence is highly conserved from fish to mammals (3-5). In representative species, for example, in human (6), rat (7), mouse (2), and, more recently, in fish models (3-5, 8), SPX is widely expressed at the tissue level, suggesting that the peptide may have pleiotropic functions. This idea is consistent with the findings that SPX is involved/implicated in gastrointestinal motility (1, 9), feeding and energy balance (4, 5), 560 press.endocrine.org/journal/endo Endocrinology, March 2017, 158(3):560-577
S pexin (SPX), the protein product of the C12orf39 gene in humans, is a novel peptide first identified by bioinformatics prior to its purification/functional studies (1, 2) . It is a 14-amino acid peptide with C-terminal a-amidation, and its protein sequence is highly conserved from fish to mammals (3) (4) (5) . In representative species, for example, in human (6) , rat (7), mouse (2) , and, more recently, in fish models (3) (4) (5) 8) , SPX is widely expressed at the tissue level, suggesting that the peptide may have pleiotropic functions. This idea is consistent with the findings that SPX is involved/implicated in gastrointestinal motility (1, 9) , feeding and energy balance (4, 5), press.endocrine.org/journal/endoluteinizing hormone release (8) , adrenocortical cell proliferation (10), nociception and cardiovascular/renal function (11) , as well as O 2 sensing in the carotid body (12) . In humans, low levels of serum SPX can be associated with insulin and lipid resistance (13), especially for type 2 diabetes (6) and both adult (14) and childhood obesity (15) , which has aroused the interest in developing SPX-based analogs with pharmacological/therapeutic potential (16) . Recently, SPX has been shown to activate galanin type 2 and 3 receptors expressed in HEK293 cells (17) , suggesting that the two receptors may act as the cognate receptors for SPX. Despite the recent progress on SPX research, there is still a lack of information regarding the endocrine control of SPX expression, and the signal transduction mechanism for SPX regulation is totally unknown.
To shed light on the comparative aspects of SPX in lower vertebrates, especially in fish species, we used goldfish as a model to establish the solution structure of fish SPX by nuclear magnetic resonance and confirm its expression at protein level within the brain by liquid chromatography-tandem mass spectrometry (4) . Using a combination of in vivo and in vitro approaches, SPX expression in brain areas involved in appetite control was shown to be elevated after food intake, and SPX treatment via differential regulation of orexigenic and anorexigenic signals within these brain areas (by increasing CART, CCK, and POMC with a concurrent drop in NPY and AgRP expression) could inhibit feeding behavior and food consumption in goldfish (4), indicating that SPX can act as a novel satiety factor in the fish model. Recently, the association of SPX expression with feeding has also been reported in fish species with commercial value, for example, grouper (3) and Ya-fish (5), which raises the possibility of using SPX as a new target for manipulating/ improving body growth and energy balance in cultured fish. Although our study in goldfish has clearly demonstrated a central component of SPX expression in appetite control, the possibility for peripheral input of SPX was not examined. Furthermore, the functional link between food intake and SPX expression as well as the underlying mechanisms for SPX regulation are still unclear and remain to be investigated.
Because insulin is a major component of glucose homeostasis after feeding, and by itself also acts as a satiety factor in mammals through modulation of orixegenic/ anorexigenic signals (18) , it raises the possibility that insulin may play a role in SPX regulation. In this study, we sought to test the hypothesis that glucose-induced insulin release/production caused by food intake might serve as a postprandial signal linking feeding with SPX expression in goldfish. Whole-animal experiments were conducted to investigate the effects of (1) food intake and (2) intraperitoneal (IP) injection of glucose and insulin, respectively, on SPX expression in the liver and/or brain areas known to be involved in appetite control in goldfish. In vitro studies were also performed in goldfish hepatocytes and brain cell culture to elucidate the receptor specificity as well as postreceptor signaling for SPX regulation by insulin using a combination of pharmacological approach and direct monitoring of activation status for signaling targets. In this study, we have provided evidence for the dual role of insulin as both the endocrine as well as autocrine/paracrine signal triggered by feeding for SPX regulation and unveiled the signal transduction mechanisms for SPX expression both in the central level (the brain) as well as at the peripheral level (the liver).
Materials and Methods

Animal and test substances
Goldfish (Carassius auratus) with 20 to 35g body weight were purchased from local pet stores and maintained in well-aerated 650-L aquaria at 20°C under 12-hour light/12-hour dark photoperiod 
, triciribine hydrate (API-2), and rapamycin, were acquired from Calbiochem (San Diego, CA). These test substances were dissolved in phosphate-buffered saline or dimethyl sulfoxide, stored frozen in small aliquots at 280°C, and diluted with prewarmed culture medium to appropriate concentrations 10 minutes prior to drug treatment.
In vivo experiments for postprandial effect of feeding and glucose/insulin treatment For in vivo experiments, goldfish (8 to 10 fish/group) were acclimated for $14 days to single housing in 25-L tanks with a one-mealper-day feeding schedule (with daily food supply at 10:00 AM). To study the postprandial effects of feeding, the fish were divided into two groups, one with a regular supply of food pellets [;1% body weight (BW), the "fed" group] and the other without food provision (the "unfed" group), and the time for daily administration of fish feed was taken as time 0 (0 hour) for reference. For in vivo treatment with glucose and insulin, IP injection of D-(+)-glucose or human insulin dissolved in fish physiological saline was conducted in goldfish under MS222 anesthesia 5 minutes prior to the regular feeding time but with no food provision after the fish recovered from the anesthesia (which took 3 to 5 minutes for full recovery). Sampling of blood and tissues was performed according to standard procedures (4) at the time points indicated. Circulating levels of glucose, insulin, and SPX were measured using a glucose LiquiColor test (Stanbio Laboratory, Boerne, TX), fish insulin enzyme-linked immunosorbent assay kit (Cusabio Life Science, Wuhan, China), and an SPX fluorescent enzyme immunoassay kit (Phoenix Pharmaceuticals, Phoenix, AZ), respectively. Total messenger RNA (mRNA) isolation, reverse transcription (RT) sample preparation, and subsequent real-time polymerase chain reaction (PCR) for target genes were carried out as described previously (19) with quantitative PCR conditions listed in Supplemental Table 1 . Authenticity of PCR products was confirmed by melting curve analysis, and parallel measurement of 18S RNA was used as the internal control. To evaluate insulin expression at tissue level and InsR and IGF1R expression both in the hepatocytes and brain cell culture, RT-PCR was also performed for tissue Figure 1 . Effects of food intake on plasma levels of glucose, insulin, and SPX in goldfish. Goldfish entrained with a one-meal-per-day feeding schedule (with eight fish per group) was provided with fish feed at 10:00 AM (taken as 0 hour as marked by the arrow) in treatment group (as "fed" group) but without food provision in the control group (as "unfed" group). Blood samples were harvested from caudal vasculature in individual fish at the time points as indicated and subjected to respective assays for the measurement of (A) plasma glucose, (B) insulin, and (C) SPX. Pearson analysis was also performed with the plasma data for (D) glucose and insulin, (E) glucose and SPX, and (F) insulin and SPX, respectively. Except for Pearson analysis (with raw data), data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05. press.endocrine.org/journal/endoexpression profiling of insulin as well as detection of multiple isoforms of InsR/IGF1R expressed in the respective cell culture with PCR protocols described in Supplemental Table 2 . In these studies, RT-PCR for b-actin was used as the quality control for RNA preparation.
In vitro experiments with goldfish hepatocytes and brain cell culture
Goldfish hepatocytes (with viability $94%) were prepared by the collagenase digestion method with minor modifications (19) and cultured in serum-free Dulbecco's modified Eagle medium/F-12 medium (Invitrogen, Carlsbad, CA) at 0.8 3 10 6 cells/mL/well in 24-well plates. Goldfish brain cells (with viability $92%) were prepared from brain areas covering the telencephalon, optic tectum, and hypothalamus by trypsin digestion as described previously (4) and cultured in 35-mm dishes at 3 3 10 6 cells/2-mL/ dish with Neurobasal (Invitrogen) containing B27 supplement (1:50 dilution). Cell cultures for the two target tissues were routinely prepared from tissues harvested from six goldfish and maintained at 28°C under 5% CO 2 and saturated humidity for 15 hours for carp hepatocytes (to avoid cell aggregation caused by prolonged culture) and 7 days for brain cells (to allow for neuron recovery and glial cell attachment) prior to initiation of drug treatment. After drug treatment, total RNA was extracted and subjected to real-time PCR for target gene measurement as described in the preceding section. Real-time PCR for 18S RNA and b-actin were also conducted to serve as the internal control for hepatocyte and brain cell culture, respectively. For in vitro studies on SPX secretion, goldfish hepatocytes were cultured at 15 3 10 6 cells/2-mL/dish in a 60-mm dish and exposed to drug treatment in the presence of a 13 dilution of Complete™ protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). After that, culture medium harvested was concentrated using C18 Sep-Pak chromatography (Waters, Tokyo, Japan) and used for SPX measurement with an SPX fluorescent enzyme immunoassay kit.
Western blot of kinase activation induced by insulin treatment
To examine the postreceptor signaling for insulin-induced SPX gene expression, Western blot was performed in cell lysate prepared from goldfish hepatocytes or brain cell culture after insulin treatment as described previously (20) using antibodies specific for the phosphorylated form (P-) and total protein (T-) of mitogen-activated protein kinase kinase (MEK) 1/2 (1:1000), extracellular signal-regulated kinase (ERK) 1/2 (1:5000), mitogen-activated protein kinase kinase (MKK) 3/6 (1:2000), p 38 mitogen-activated protein kinase (P 38 MAPK ) (1:1000), phosphatidylinositol 3-kinase (PI3K) (1:2000) , and Akt (1:1500), respectively. (Table 1 provides details of these antibodies and their respective suppliers.) In these studies, parallel blotting of b-actin was used as the loading control. Quantitation of the results of Western blot was performed by densitometric scanning using ImageJ (https://imagej.nih.gov/ij/), and the data were Total RNA was isolated from the tissue/brain area as indicated and subjected to RT-PCR with primers specific for goldfish insulin. The authenticity of PCR product was confirmed by PCR Southern analysis using a digoxigenin-labeled probe for goldfish insulin, and RT-PCR for b-actin was used as internal control. Effects of food intake on (B) insulin and (C) SPX gene expression in the liver of goldfish. In the same study described in Fig. 1 , total RNA was isolated from the liver at the respective time points in the "fed" ad "unfed" groups and subjected to real-time PCR for insulin and SPX mRNA measurement. Parallel measurement of 18S RNA was performed to serve as the internal control for data normalization. Data presented for the temporal changes of insulin and SPX mRNA levels are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05.
transformed as a ratio of the phosphorylated form over the total protein of the respective targets.
Data transformation and statistics
For real-time PCR, standard curves with a dynamic range of $10 5 and correlation coefficient of $0.95 were constructed for data calibration with serial dilutions of plasmids carrying the open reading frame of target genes. The raw data of mRNA expression for in vivo experiments (in terms of femtomoles of transcript detected per assay tube) were normalized against 18S RNA expression detected in the same sample and transformed as a percentage of the mean value for target gene expression in control group at time 0 (i.e., as "% Ctrl" of the reference group at 0 hour). For in vitro experiments with cell culture, the raw data of mRNA expression were measured in terms of femtomoles of transcript/10 6 cells/well. These data were normalized against b-actin mRNA in the case of brain cell culture and transformed as a percentage of the control group without drug treatment (as % Ctrl). Because 18S RNA levels (the internal control for hepatocytes) did not exhibit notable changes in our in vitro experiments, the raw data for target gene expression in goldfish hepatocytes were simply transformed as a percentage of the mean value in the control (as % Ctrl) or fold increase vs the control group (as "fold induction") without 18S RNA normalization . Data presented for plasma levels of glucose and insulin as well as for realtime PCR of target gene expression are expressed as mean 6 standard error of the mean (SEM) (n = 8 to 10 for in vivo experiments and 4 to 8 for in vitro experiments). Data for time-course studies were analyzed with two-way analysis of variance followed by a Bonferroni post hoc test with time and treatment as the two Figure 3 . In vivo treatment with glucose on central and peripheral expression of SPX in goldfish. Fish entrained with one-meal-per-day feeding schedule (eight fish per group) were IP injected with D-(+)-glucose (1.5 mg/g BW) at 10:00 AM (taken as 0 hour) without food provision. Parallel injection with physiological saline was used as the control. (A) At the time points as indicated, blood samples were collected for measurement of plasma glucose. For peripheral tissue, total RNA was isolated from the liver at the respective time points for real-time PCR of (B) insulin and (C) SPX mRNA expressed at the hepatic level. For central expression of SPX, RNA samples were isolated from (D) the hypothalamus, (E) telencephalon, and (F) optic tectum, respectively, and used for SPX mRNA measurement in selected brain areas. In this study, parallel measurement of 18S RNA was used as the internal control. Data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05. press.endocrine.org/journal/endovariables for statistical analysis. The data for dose-dependence/drug treatment to elucidate postreceptor signaling were analyzed with one-way analysis of variance followed by a Newman-Keuls test. Differences between groups were considered as significant at P , 0.05.
Results
Functional role of insulin in SPX regulation in vivo
In goldfish entrained with a one-meal-per-day feeding schedule, significant increases in glucose, insulin, and SPX levels were observed in the plasma with peaks at 1 hour after initiation of feeding (at time 0) when compared with the time-matched unfed groups [ Fig. 1(A-C) ]. In the unfed groups, however, plasma levels of glucose, insulin, and SPX were reduced in a time-dependent manner with respect to their preprandial basal levels. Pearson analysis of the data for plasma samples also revealed that a positive correlation could be noted between plasma levels of insulin and glucose [ Fig. 1(D) ], SPX and glucose [ Fig. 1(E) ], and SPX and insulin [ Fig. 1(F) ]. In goldfish, as revealed by RT-PCR, insulin was found to be widely expressed in different tissues (e.g., the brain, gills, heart, gut, spleen, kidney, liver, muscle, and gonads) and brain areas (e.g., the olfactory bulb, telencephalon, optic tectum, hypothalamus, pituitary, cerebellum, medulla oblongata, and spinal cord), with the highest level of insulin signal detected in the liver Fig. 3(F) ]. To examine the role of insulin in SPX regulation, IP injection of human insulin was also performed in goldfish. Insulin of human origin was used because (1) fish insulin with bioactivity is not commercially available, and (2) human insulin is highly homologous to its goldfish counterpart (84% in the B-domain and Figure 4 . In vivo treatment with insulin on central and peripheral expression of SPX in goldfish. Fish entrained with one-meal-per-day feeding schedule (eight fish per group) were IP injected with insulin (4 United States Pharmacopeia U/g BW) at 10:00 AM (taken as 0 hour) without food provision. Parallel injection with physiological saline was used as the control. At the time points as indicated, blood samples were collected for (A) plasma glucose and (B) SPX measurement. Meanwhile, total RNA was isolated from (C) the liver and brain areas, including the (D) hypothalamus, (E) telencephalon, and (F) optic tectum, for real-time PCR of SPX mRNA measurement. Parallel measurement of 18S RNA was also conducted to serve as the internal control. Data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05.
78% in the A-domain, which form the mature peptide of insulin). In our study, IP injection with human insulin was shown to reduce plasma levels of glucose in goldfish [ Fig. 4  (A) ], indicating that human insulin is fully functional in the fish model. Meanwhile, plasma levels of SPX [ Fig. 4(B) ] as well as SPX mRNA expression in the liver [ Fig. 4(C) ] and brain areas, including the hypothalamus [ Fig. 4(D) ], telencephalon [ Fig. 4(E) ], and optic tectum [ Fig. 4(F Fig. 5(F) ]. These stimulatory effects, however, were found to be suppressed/totally abolished by S961 cotreatment.
SPX regulation by insulin in goldfish hepatocytes
To shed light on SPX regulation by insulin at the hepatic level, primary culture of hepatocytes was prepared from goldfish (Supplemental Fig. 2A) , and validation based on growth hormone-induced IGF-I mRNA expression also confirmed that the cell culture was responsive to hormone stimulation under serum-free conditions (Supplemental Fig. 2B ), which is highly desirable for subsequent investigation of insulin action. In mammals, insulin and IGF-I are known to cross-react at the receptor level (21) . In our study, the receptor specificity for SPX regulation by insulin was also examined at the hepatic level. In goldfish hepatocytes, insulin Parallel injection with saline was used as the control. Blood sampling and tissue collection were conducted 30 minutes after drug treatment. Plasma samples prepared were used for measurement of (A) plasma glucose and (B) SPX levels. For peripheral expression of SPX, total RNA was isolated from the liver for real-time PCR of SPX mRNA expression at the hepatic level (C). For central expression of SPX, RNA samples were isolated from the (D) hypothalamus, (E) telencephalon, and (F) optic tectum, respectively, and used for SPX mRNA measurement in selected brain areas. In this study, parallel measurement of 18S RNA was used as the internal control. Data presented are expressed as mean 6 SEM (n = 10), and groups denoted by different letters represent a significant difference at P , 0.05. Fig. 7(D) ], and again, a marginal inhibition was noted with parallel inhibition using the IGF1R blocker PPP (data not shown).
To shed light on the effect of InsR activation on SPX secretion at the hepatic level, a high-density culture system supplemented with Complete™ protease inhibitor cocktail was established for goldfish hepatocytes. Based on our validation, the protease inhibitors did not alter the viability or overall morphology of our cell culture (Supplemental Fig. 3A ) and had no notable effect on insulin, SPX and b-actin gene expression (Data not shown). Using this high-density cell culture, a 2-hour treatment with D-(+)-glucose (Supplemental Fig. 3B ) or insulin (Supplemental Fig. 3C ) was found to elevate SPX release, and the stimulatory effect by D-(+)-glucose could be negated by cotreatment with the InsR inhibitor HNMPA (Supplemental Fig. 3D ). Given that InsR is known to be functionally coupled with MAPK and PI3/Akt pathways (22) , the possible involvement of these postreceptor signaling cascades in SPX expression induced by insulin was also examined. Similar to the rapid phosphorylation of InsR, insulin treatment was effective in triggering protein phosphorylation of MEK 1/2 , ERK 1/2 , MKK 3/6 , P 38 MAPK , PI3K, and Akt in goldfish hepatocytes, with peaks at 15 minutes after drug administration [ Fig. 8(A-C) ]. In parallel studies with insulin treatment in the presence of inhibitors for various signaling targets, SPX mRNA expression IGF1R 2 ) expressed in the liver and hepatocyte culture prepared from goldfish using primers for the respective gene targets. RT-PCR for InsR and IGF1R expressed in muscle was used as positive control, and parallel PCR for b-actin was used as internal control. Regulation of SPX mRNA expression in primary culture of goldfish hepatocytes: dose dependence of glucose treatment on (B) insulin and (C) SPX mRNA expression in goldfish hepatocytes. Hepatocytes were treated for 48 hours with increasing concentrations of D-(+)-glucose and subjected to RNA isolation and real-time PCR for insulin and SPX mRNA measurement. Time course of (D) insulin and (E) glucagon treatment on SPX mRNA expression. Goldfish hepatocytes were incubated with insulin (100 nM) or glucagon (100 nM) for the duration as indicated. Dose dependence of insulin (F) on SPX mRNA expression was also examined in the cell culture with duration of drug treatment fixed at 48 hours. Data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05. Furthermore, insulin-induced SPX gene expression could be totally abolished by exposing goldfish hepatocytes to the P 38 MAPK inhibitor PD169316 and PI3K inactivator LY294002 at the same time [ Fig. 9(F) ].
SPX regulation by insulin in goldfish brain cells
Because insulin treatment, similar to glucose challenge, could elevate SPX gene expression in vivo in the telencephalon, hypothalamus, and optic tectum of the goldfish, goldfish brain cell culture was prepared from these brain areas (4) and used as a cell model to study the central actions of insulin on SPX regulation. In this cell culture, B27 supplement (with 4 mg/L insulin; Invitrogen) was used as a serum substitute to maintain a serum-free culture condition. To examine the effect of removing insulin intrinsic to the cell culture system, the serum substitute was replaced with an insulin-free preparation of B27 (Invitrogen). In this case, basal expression of SPX mRNA was reduced to a low level but with no effect on b-actin gene expression [ Fig. 10(A) ]. In brain cells cultured with normal preparation of B27, insulin treatment was found to have the opposite effect and elevate SPX mRNA levels in a time-related [ Fig. 10(B) ] and doserelated fashion [ Fig. 10(C) ], with peak responses observed at 12 hours after initiation of drug treatment.
As revealed by RT-PCR, transcript signals of the receptors for insulin (including InsR 1 and InsR 2 ) and IGF-I (including IGF1R 1 and IGF1R 2 ) could be detected in the brain as well as brain cell culture prepared from the goldfish [ Fig. 10(D) ], implying that the central nervous system (CNS) is a regulatory target for insulin and IGF-I in the fish model. In goldfish brain cells, SPX mRNA expression induced by insulin could be totally negated by the InsR inhibitor HNMPA, whereas the parallel blockade with IGF1R inactivator PPP could only yield a partial inhibition [;50%, Fig. 10(E) ]. Regarding the postreceptor signaling for insulin induction, similar to the results in hepatocytes, insulin was effective in triggering rapid press.endocrine.org/journal/endo Figure 8 . Effects of insulin on MAPK and PI3K/Akt signaling in goldfish hepatocytes. Hepatocytes were treated with insulin (10 nM) for the duration as indicated. After that, cell lysate was prepared and subjected to Western blot using antibodies for phosphorylated form (P-) and total protein (T-) of (A) MEK 1/2 and ERK 1/2 , (B) MKK 3/6 and P 38
MAPK
, and (C) PI3K and Akt, respectively. Parallel Western blot for b-actin was used as the loading control. Representative results of Western blot are shown in the panels on the left, whereas the quantitative data expressed as the ratio of the signal intensity (registered by densitometric scanning using ImageJ) of the P-form over the T-form of target protein are presented in the right panels. Data presented are expressed as mean 6 SEM (n = 4), and groups denoted by different letters represent a significant difference at P , 0.05. phosphorylation of MEK 1/2 , ERK 1/2 , MKK 3/6 , P 38 MAPK , PI3K, and Akt in brain cell culture [ Fig. 11 ]. Parallel experiments also revealed that SPX mRNA expression induced by insulin was not sensitive to the blockade by the MEK 1/2 inhibitor PD98059 or ERK 1/2 blocker FR180204 [ Fig. 12(A) ]. In contrast, the SPX responses could be obliterated by cotreatment of insulin with the P 38 MAPK inhibitor PD169316, PI3K inactivator LY294002, Akt blocker API-2, and mTOR inhibitor rapamycin [ Fig. 12 ].
As shown in our tissue profiling for insulin expression [ Fig. 2(A) ], insulin signal was also located in the brain of goldfish, especially in the hypothalamus, telencephalon, and optic tectum. These findings raise the possibility that insulin produced locally within the brain may play a role in SPX regulation by glucose in the CNS. In our in vivo experiment, however, IP injection of D-(+)-glucose consistently increased plasma insulin and insulin mRNA levels in the liver (positive control of the study) but with no effect on insulin gene expression in hypothalamus, telencephalon, and optic tectum (Supplemental Fig. 4A ). In a parallel study with goldfish brain cell culture, similarly, treatment with D-(+)-glucose up to 24 hours was found to be ineffective in altering basal levels of insulin and SPX mRNA expression (Supplemental Fig. 4B ). These results suggest that insulin expression within the brain of goldfish is not responsive to glucose changes in circulation. Probably, insulin from circulation rather than blood glucose represents the major signal for SPX regulation within the CNS.
Discussion
SPX, a novel peptide identified by bioinformatics (1), has recently emerged as a regulatory factor with pleiotropic functions (see the Introduction for details). Because its association with energy balance and obesity has been reported in human and animal models (14) , and plasma levels of SPX can be used as a marker for childhood obesity (15) and type 2 diabetes (6), studies on SPX have aroused a lot of interest in the field. The research on SPX has become even more interesting with our recent study in goldfish revealing that central expression of SPX induced by food intake could act as a satiety signal to inhibit feeding behavior in a fish model via modulation of orexigenic/anorexigenic factors expressed in brain areas involved in appetite control (4) . Given that insulin, a key component of glucose homeostasis, is responsive to feeding, and by itself also acts as an anorexigenic factor for signal integration of satiation and body adiposity (23), we postulate that it may be involved Figure 9 . Blocking MAPK and PI3K/Akt signaling cascades on insulin-induced SPX mRNA expression in goldfish hepatocytes. Hepatocytes were incubated with insulin (10 nM) for 48 hours in the presence of (A) the MEK 1/2 inhibitor U0126 (10 mM) or PD98059 (10 mM), (B) the ERK 1/2 inhibitor FR180204 (2 mM) or SCH772984 (10 nM), (C) the P 38 MAPK inhibitor PD169316 (10 mM) or SB203580 (10 mM), (D) the PI3K inhibitor LY294002 (10 mM) or wortmannin (100 nM), and (E) the Akt inhibitor API-2 (20 mM) or mTOR inhibitor rapamycin (20 nM), respectively. In a parallel study, insulin induction (10 nM) was also tested with cotreatment of MEK 1/2 inhibitor PD169316 (10 mM) and PI3K inhibitor LY294002 (10 mM) simultaneously (F). After drug treatment, total RNA was isolated and subjected to real-time PCR for SPX mRNA measurement. Data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05. doi: 10.1210/en.2016-1534 press.endocrine.org/journal/endoin SPX expression in the fish model. In our feeding experiment, food intake could elevate plasma levels of glucose, insulin, and SPX in goldfish with concurrent increase in insulin and SPX gene expression in the liver. Our results demonstrated that, besides the central expression of SPX, feeding could also induce a peripheral component of SPX, presumably through elevation of SPX production in the liver followed by SPX release into systemic circulation. Because (1) glucose-induced insulin release via ATP-sensitive K + channels (24) and sweet taste-sensing receptors (25) coupled to mitochondrial signal amplification (26) is well documented, and (2) a positive correlation was noted for plasma levels of glucose, insulin, and SPX in our feeding experiment, it raises the possibility that glucose-induced insulin signals caused by feeding might play a role in SPX regulation. This idea is supported by our findings that (1) IP injection of glucose in goldfish could elevate plasma insulin and hepatic expression of insulin and SPX mRNA levels, and (2) parallel treatment with insulin not only could induce SPX gene expression in the liver but also increase plasma levels of SPX. In both cases, SPX mRNA levels in brain areas involved in appetite control (i.e., hypothalamus, telencephalon, and optic tectum) were also increased by glucose and insulin induction. Given that glucoseinduced SPX secretion and SPX gene expression in the brain and liver were also sensitive to in vivo blockade by the insulin antagonist S961, it would be logical to conclude that the insulin signal caused by postprandial rise in blood glucose can contribute to the SPX responses within the CNS and at the hepatic level in a fish model. In bony fish, endocrine pancreas exists as Brockman bodies scattering in the gut mesentery, for example, in tilapia (27) and wolfish (28) , whereas exocrine pancreas (mainly in the form of glandular acinus) can also spread into the liver, leading to the formation of hepatopancreas in some species (29) . Although hepatopancreas has been reported in goldfish (30) , the presence of an endocrine component of the pancreas has not been documented at the hepatic level. In our study, distinct structure for Brockman bodies could not be identified in the goldfish, but the highest level of insulin expression was located in IGF1R 2 ) was conducted in the brain as well as brain cells prepared from goldfish (D) using primers specific for the respective gene targets. RT-PCR for InsR and IGF1R expressed in muscle was used as the positive control whereas parallel PCR for b-actin was used as internal control. For functional studies, blockade of InsR and IGF1R on insulin-induced SPX mRNA expression were also tested in goldfish brain cells (E). In this case, brain cells were incubated with insulin (30 nM) for 12 hours in the presence/absence of the InsR inhibitor HNMPA (10 mM) or IGF1R inhibitor PPP (10 mM). After treatment, total RNA was isolated and subjected to real-time PCR for SPX mRNA measurement. Parallel measurement of b-actin mRNA was used as the internal control. Data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05. the liver. Furthermore, our experiments with IP injection of glucose in vivo and glucose treatment in hepatocytes in vitro have clearly shown that insulin signals not only could be detected at the hepatic level but also inducible by glucose with a parallel increase in SPX gene expression. In goldfish hepatocytes, glucose and insulin induction were both effective in elevating SPX mRNA levels, and glucose-induced SPX secretion and gene expression could be negated by insulin antagonist S961 and/or InsR inhibitor HNMPA. These findings, taken together, suggest that (1) an insulin component responsive to glucose induction is present in the goldfish liver, and (2) local production of insulin induced by glucose may act in an autocrine/paracrine manner to trigger SPX release/expression at the hepatic level. In mammals, autocrine/paracrine actions of insulin have also been reported in the brain and involved in cognitive functions related to memory, learning, and food anticipation (31) . However, the local action of insulin produced at the hepatic level has not been reported. Because glucagon did not alter SPX gene expression in our hepatocyte culture, it would be logical to assume that local production of glucose (e.g., by glycogenolysis/ gluconeogenesis) may not have a major role in SPX regulation. Judging from the fact that the liver represents the largest organ in the body and serves as a major target for insulin, especially for glucose (32) and lipid homeostasis (33) , the hepatopancreas in goldfish with an inducible component of insulin may also act as a source of insulin for both local actions as well as endocrine functions via blood circulation. Although Brockman bodies could not be identified in goldfish, we do not exclude the possibility that postprandial rise in blood glucose could also induce insulin release from goldfish pancreas, which may also contribute to SPX regulation in the liver as well as in brain areas involved in appetite control. Brain cells were challenged with insulin (10 nM) for the duration as indicated. After that, cell lysate was prepared and subjected to Western blot using antibodies for phosphorylated form (P-) and total protein (T-) of (A) MEK 1/2 and ERK 1/2 , (B) MKK 3/6 and P 38 MAPK , and (C) PI3K and Akt, respectively. Parallel Western blot for b-actin was used as the loading control. Representative results of Western blot are shown in the panels on the left, whereas the quantitative data expressed as the ratio of the signal intensity (registered by densitometric scanning using ImageJ) of the P-form over the T-form of target protein are presented in the right panels. Data presented are expressed as mean 6 SEM (n = 4) and groups denoted by different letters represent a significant difference at P , 0.05. doi: 10.1210/en.2016-1534 press.endocrine.org/journal/endo
Of note, glucose treatment, both in vivo and in vitro, did not alter hepatic expression of IGF-I/IGF-II mRNA levels in our studies, the possible involvement of local production of IGFs for SPX regulation is rather unlikely. In mammals, insulin is known to cross-react with IGF1R (21) , and InsR and IGF1R are functionally coupled with MAPK and PI3K/Akt pathways (34) . In some tissues (e.g., placenta), InsR and IGF1R can also form hybrid receptors (35) with higher affinity for IGF-I (36). In bony fish, isoforms of InsR (37) and IGF1R (38) have been cloned and are thought to be the result of whole-genome duplication occurring during the evolution of the teleost lineage (39) . In goldfish hepatocytes, two forms of InsR (InsR 1 and InsR 2 ) and one form of IGF1R (IGF1R 2 ) could be identified by RT-PCR, and insulin exposure was found to induce rapid phosphorylation of InsR and IGF1R, suggesting that the receptors for insulin and IGF-I may play a role in mediating insulin functions at the hepatic level. Given that (1) the InsR inhibitor HNMPA was notably more effective (83% blockade) than the IGF1R inhibitor PPP (16% blockade) in attenuating insulininduced SPX mRNA expression in goldfish hepatocytes, and (2) the SPX responses caused by insulin were totally abolished by PQ401, an inhibitor known to inactivate both InsR and IGF1R at the dose tested, it is conceivable that the two receptors are both involved in SPX regulation at hepatic level, with InsR as the dominant form mediating insulin action. Regarding the postreceptor signaling mechanisms for SPX regulation, insulin was capable of triggering MEK 1/2 , ERK 1/2 , MKK 3/6 , P 38 MAPK , PI3K and Akt phosphorylation in goldfish hepatocytes. These results are comparable with the recent report on InsR signaling in trout adipocytes (40) and consistent with the idea that InsR signaling via MAPK and PI3K/Akt cascades is well conserved in vertebrate evolution (41) . In goldfish hepatocytes, however, insulin-induced SPX mRNA expression was not affected by the inhibitors for MEK 1/2 (U0126 and PD98059) or ERK 1/2 (FR18024 and SCH772984), but it was attenuated by the inhibitors for P 38 MAPK (PD169316 and SB20380), PI3K (LY294002 and wortmannin), Akt (API-2), and mTOR (rapamycin). Besides, the SPX responses caused by insulin could be totally negated by cotreatment with the inhibitors for P 38 MAPK (PD169316) and PI3K (LY294002), suggesting that the MKK 3/6 /P 38 MAPK and PI3K/Akt/mTOR but not MEK 1/2 /ERK 1/2 cascades are involved in SPX gene expression induced by insulin at the hepatic level in the carp model.
As mentioned in the preceding section, insulin signals induced by glucose could also trigger SPX gene expression in brain areas involved in appetite control, which might initiate the satiation response after feeding in goldfish via differential regulation of orexigenic/ anorexigenic signals within the CNS. This idea is comparable to the model in mammals with central regulation of energy balance and body weight via modulation of feeding regulators (e.g., NPY and POMC) within the hypothalamus by satiety signals (e.g., leptin) (42) . In our study, the effect of insulin on central expression of SPX was further substantiated by in vitro experiments with goldfish brain cells, in which (1) removing insulin from the cell culture system (using insulin-free B27) could suppress the basal level of SPX mRNA, and (2) insulin treatment, in contrast, could upregulate SPX gene expression in a time-and dose-related manner. Our findings are also in agreement with the previous reports (e.g., in Figure 12 . Blocking MAPK and PI3K/Akt signaling cascade on insulin-induced SPX mRNA expression in goldfish brain cells. Primary culture of goldfish brain cells was incubated with insulin (30 nM) for 12 hours with/without (A) the MEK 1/2 inhibitor PD98059 (10 mM), ERK 1/2 inhibitor FR180204 (2 mM), or P 38 MAPK inhibitor PD169316 (10 mM), or (B) PI3K inhibitor LY294002 (10 mM), Akt inhibitor API-2 (20 mM), or mTOR inhibitor rapamycin (20 nM), respectively. After drug treatment, total RNA was isolated and subjected to realtime PCR for SPX mRNA measurement. In these experiments, parallel measurement of b-actin mRNA was used as internal control. Data presented are expressed as mean 6 SEM (n = 8), and groups denoted by different letters represent a significant difference at P , 0.05. rodents) on (1) insulin uptake into the CNS by transcytosis across the choroid plexus via InsR coupled to LRP2/megalin (43) , and (2) the role of insulin as an anorexigenic factor via its central actions in modulating NPY, AgRP, POMC, and MCR4 expression (44) . Apparently, SPX can serve as a novel component for the central actions of insulin on appetite control. Because insulin expression within the brain in goldfish was not responsive to glucose in vivo and in vitro, it is likely that insulin from circulation rather than blood glucose represents the key signal triggering SPX expression within the CNS in the fish model. Regarding the receptor specificity for insulin's action within the CNS, the results of RT-PCR revealed that multiple isoforms of InsR (InsR 1 and InsR 2 ) and IGF1R (IGF1R 1 and IGF1R 2 ) could be detected in the whole brain as well as brain cell culture prepared from the goldfish. Similar to goldfish hepatocytes, insulin-induced SPX mRNA expression in brain cells was found to be more sensitive to the blockade by the InsR inhibitor HNMPA (;100%) compared with similar treatment with the IGF1R inhibitor PPP (;50% blockade). These results again suggest that the central effect of insulin on SPX expression is mediated mainly by InsR and to a lower extent by IGF1R. Unlike in the brain, IGF1R 1 was undetectable in goldfish liver/hepatocytes, and IGF1R 2 was the only IGF1R identified at the hepatic level, implying that different isoforms of IGF1R are expressed in a tissue-specific manner. Whether it can also contribute to the tissue-specific actions of IGFs as recently reported for insulin/IGF-I signaling in body metabolism and aging in rodents (45) is unclear and remains to be investigated. Although insulin was effective in triggering protein phosphorylation of MEK 1/2 , ERK 1/2 , MKK 3/6 , P 38 MAPK , PI3K, and Akt in goldfish brain cells, SPX mRNA expression induced by insulin in the cell culture was not sensitive to the blockade of MEK 1/2 (e.g., by PD98059) and ERK 1/2 (e.g., by FR180204) but could be totally abolished by inhibiting P 38 MAPK (e.g., by PD169316), PI3K (e.g., by LY294002), Akt (e.g., by API-2), and mTOR (e.g., by rapamycin), respectively. These findings as a whole confirm that, similar to the case of goldfish hepatocytes, the central effect of insulin on SPX regulation is also mediated by MKK 3/6 /P 38 MAPK and PI3K/ Akt/mTOR but not MEK 1/2 /ERK 1/2 cascades. In summary, using goldfish as an animal model, we have demonstrated that insulin signals induced by a postprandial rise in blood glucose could serve as the functional link between food intake and SPX expression both in the central (i.e., within CNS) and peripheral (i.e., in the liver) levels. In our study, we also found that the liver in goldfish represents a major site of insulin expression, which is also inducible by changes in glucose levels. In our working model (Fig. 13) , food intake in goldfish can induce insulin expression in the liver via Figure 13 . Working model for insulin acting as a functional link between feeding and SPX expression in the liver as well as in the brain of the fish model. In goldfish, food intake can induce insulin expression in the liver via elevation in blood glucose (probably with parallel rise in insulin signal from the pancreas). Local production of insulin acts in an autocrine/paracrine manner to upregulate SPX expression at the hepatic level mainly via InsR (to a lesser extent by IGF1R) functionally coupled with the MKK 3/6 /P 38 MAPK and PI3K/Akt pathways. SPX produced by the liver enters the systemic circulation and serves as a peripheral signal acting on the CNS. Meanwhile, insulin released from the liver (together with insulin from the pancreas) can elevate insulin level in circulation and exerts a central effect to induce SPX expression in brain areas involved in feeding control via InsR coupled to MKK 3/6 /P 38 MAPK and PI3K/Akt signaling. The combined effect of central expression of SPX together with the peripheral input of SPX can differentially regulate orexigenic and anorexigenic signals expressed in the feeding circuitry within the CNS and lead to an inhibition on feeding behavior and subsequent suppression of food intake. These biological changes are thought to play a role in the initiation of satiation response after feeding in the fish model. press.endocrine.org/journal/endoelevation in blood glucose (probably with a parallel rise in insulin signal from the pancreas). Local production of insulin acts in an autocrine/paracrine manner to increase SPX expression at the hepatic level via InsR (to a lesser extent via IGF1R) coupled to the MKK 3/6 /P 38 MAPK and PI3K/Akt pathways. Hepatic output of SPX also elevates SPX level in circulation and constitutes a peripheral SPX signal acting on the CNS. Meanwhile, insulin released from the liver (together with pancreatic insulin) can elevate insulin level in blood and serve as an endocrine signal to induce SPX expression in brain areas involved in feeding behavior. Apparently, the central effect of insulin on SPX expression is also mediated through InsR coupled with MKK 3/6 /P 38 MAPK and PI3K/Akt signaling. Because our previous study with intracerebroventricular injection of SPX in goldfish confirmed that (1) SPX by acting centrally could inhibit feeding behavior and food intake, and (2) these inhibitory effects were mediated by SPX inhibition of NPY and AgRP, with concurrent stimulation of CART, CCK, and POMC expression in brain areas involved in appetite control (4), local production of SPX within the CNS together with the SPX input from the periphery induced by insulin presumably can inhibit feeding behavior in goldfish via differential actions on orexigenic/anorexigenic signals within the feeding circuitry in the brain. Our study, as a whole, has provided new insights on the mechanisms and signal transduction for the role of SPX as a satiety factor in a fish model. Of note, plasma SPX is closely associated with glucose homeostasis (e.g., in diabetic patients) (6) and fatty acid uptake/body adiposity (e.g., in obese mice) (14) . The role of circulating SPX induced by feeding in energy balance and glucose/lipid metabolism will certainly be an interesting topic for further study. Recently, type 2 and 3 galanin receptors have been proposed to be the cognate receptor for SPX, and, interestingly, the type 3 galanin receptor could not be found in the genome of fish species (e.g., zebrafish) (17) . Research is now under way in our laboratory to study the receptor specificity as well as the postreceptor signaling mechanisms for SPX-induced satiation and regulation of orexigenic/anorexigenic factors expressed within the brain in goldfish.
